Presentaciones en Congresos
1. Paz R., Fernández O., Herrera E., Barros C.
“Study of the dog ovum with electronic microscopy” Libro de Resúmenes I Congreso de Estudiantes de Morfología. 1985.
2. Mosso L., Paz R., Lavados M Serani, A.
“Evaluation of the information process in doctor-patient relationship” Libro de Resúmenes. XV Congreso Científico de Estudiantes de Medicina. 1991.
3. Valdivieso S., Paz R., Fischman P.
“Conceptual precisions related to personality disorders” Libro de Resúmenes XLVIII. Congreso Chileno de Neurología, Psiquiatría y Neurología. 1997.
4. Paz, R., Seguel M.
“Evaluation of a neglected screening-instrument for alcoholism detection” Libro de resúmenes” I Congreso de la Asociación Iberoamericana para el estudio de los problemas del Alcohol y Drogas (AIEPAD). 1994.
5. Paz, R., Nachar R., Alvarez L., Hormazabal L.
“Clinical experience with Lamotrigine in refractory mood disorders” Libro de resúmenes L I Congreso de la Sociedad de Neurología , Psiquiatría y Neurocirugía . Viña del Mar. Chile. 1998.
6. Paz R., Nachar. R., Alvarez L., Hormazabal L.
“Lamotrigine in mood disorders, review of evidence” Libro de resúmenes L I Congreso de la Sociedad de Neurología y Psiquiatría 1998.
7. Paz R., Tardito S.
“High doses of Olanzapine in a schizophrenic patient resistant to traditional neuroleptics”. Libro de resúmenes L I Congreso de la Sociedad de Neurología y Psiquiatría 1998.
8. Paz R., Ortíz V., Alvarado S., Ocampo C., Villar R., Graver C.
“The clinical profile of forensic psychiatric inpatients” Primeras jornadas científicas Instituto Psiquiátrico Dr. José Horwitz Barak 1999.
9. Paz R., Tardito, S.
“Supra-maximal doses of Olanzapine in schizophrenic patients resistant to treatment” Primeras Jornadas Científicas Instituto Dr. José Horwitz Barak 1999.
10. Paz R., Nachar R., Alvarez L., Hormazabal L.
“Lamotrigine in fifty five mood disorder patients resistant to conventional treatments” Primeras Jornadas Científicas Instituto Dr. José Horwitz Barak 1999.
11. Paz R., Nachar R., Alvarez L., Hormazabal L.
“Lamotrigine in fifty five mood-disordered patients resistant to conventional treatments; a two-year follow up study” Segundas Jornadas Científicas Instituto Dr. José Horwitz Barak 2000.
12. Paz R.
“Clinic experience with the use of Clozapine in eighteen bipolar patients resistant to conventional treatments” Libro de resúmenes LII Congreso de la Sociedad de Neurología, Psiquiatría y Neurocirugía. 2000.
13. Paz R.
“Clozapine in eight mentally retarded or brain-damaged-patients refractory to conventional treatments” Libro de resúmenes LII Congreso de la Sociedad de Neurología, Psiquiatría y Neurocirugía. 2000.
14. Bitran J.,Paz R.
“Clozapine in mood disorder patients, clinic and neurobiological aspects” Libro de resúmenes LII Congreso de la Sociedad de Neurología, Psiquiatría y Neurocirugía. 2000.
15. Paz R., Ortiz V., Alvarado S.
“Clozapine treatment in forensic patients; Impact in substance abuse and aggressiveness” Libro de resúmenes LII Congreso de la Sociedad de Neurología, Psiquiatría y Neurocirugía. 2000.
16. Paz R, Bitran J., Quiroz D., Hormazabal L., Labarca R.
“Clozapine low doses in refractory bipolar disorder” New Research Abstracts, American Psychiatric Association, Annual Meeting, New Orleans. 2001.
17. Paz R Andreasen N, Perrone-Bizzozero N
“Testing an hypothesis of cerebellar granule cell dysfunction in schizophrenia“ IX Meeting of the International Society on Schizophrenia Research. Colorado Springs 2003. Published in Schizophrenia Research 2003: 60: 66
18. Paz R., Allan A., Caldwell K.
“Environmental enrichment reverses deficits in trace fear conditioning produced by fetal alcohol exposure“ Society for Neuroscience, Annual Meeting, New Orleans, 2003
19. Atzori M., Paz R.
“Dopamine blocks muscarinic depression of glutamate release: a psychotogenic mechanism?” Society for Neuroscience, Annual Meeting, New Orleans 2003
20. Paz R., Merhge M., Roberts R., Conley R., Andreasen N., Perrone-Bizzozero N.
“Gene expression analyses in the cerebellum of patients with schizophrenia suggest that a GABAergic dysfunction of Golgi cells leads to hyperactivity of glutamatergic granule cells” Society of Biological Psychiatry, Annual Meeting, New York, 2004. Published in Biological Psychiatry 2004:55; 128S
21. Paz R., Caldeira J., Allan A., Caldwell K.
“Trace conditioning deficits and low levels of BDNF protein suggest that medial frontal cortex is hypoactive in mice prenatally exposed to ethanol in uterus” Society for Neuroscience Annual Meeting. San Diego 2004
22. Paz R., Caldeira J., Allan A., Caldwell K.
“ Deficits in consolidation but not acquisition of the extinction of fear conditioned responses in FAE mice suggest that medial frontal cortex is impaired in these animals” International Extinction Conference. Puerto Rico. 2005
22. Paz R., Andreasen N.,Daoud s.,Conley R., Roberts R., Bustillo J., Perrone-Bizzozero N.
“Increased expression of granule-cell specific, activity-dependent genes in postmortem cerebellar tissue suggests that these neurons are hyperactive in schizophrenia” X Meeting of the International Society on Schizophrenia Research. Savannah 2005. Published in Schizophrenia Bulletin 2005: 31; 255
23. Paz R., Andreasen N.,Daoud s.,Conley R., Roberts R, Perrone-Bizzozero N.
“Alcohol abuse or dependence is associated with decreased activity of cerebellar granule cells in patients with schizophrenia biut not in control subjects” X Meeting of the International Society on Schizophrenia Research. Savannah 2005. Published in Schizophrenia Bulletin 2005: 31; 255
24. Bustillo J., Barrow R., Perrone-Bizzozero N., Lauriello J., Paz R., Galloway M.
“ Effects of long-term haloperidol exposure on N-Acetylaspartate and other metabolites measured with H-MRS at 11.7T in rats” X Meeting of the International Society on Schizophrenia Research. Savannah 2005. Published in Schizophrenia Bulletin 2005: 31; 296